These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27073590)

  • 1. SIRT1: A Novel Target for the Treatment of Muscular Dystrophies.
    Kuno A; Horio Y
    Oxid Med Cell Longev; 2016; 2016():6714686. PubMed ID: 27073590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
    Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
    J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
    Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
    Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.
    Kuno A; Tanno M; Horio Y
    Ann N Y Acad Sci; 2015 Aug; 1348(1):46-54. PubMed ID: 26109180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
    Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
    PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
    Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of free radicals in the pathophysiology of muscular dystrophy.
    Tidball JG; Wehling-Henricks M
    J Appl Physiol (1985); 2007 Apr; 102(4):1677-86. PubMed ID: 17095633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review on the Role of SIRT1 in Duchenne Muscular Dystrophy.
    Domi E; Hoxha M; Prendi E; Zappacosta B
    Cells; 2021 Jun; 10(6):. PubMed ID: 34205021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy.
    Desguerre I; Arnold L; Vignaud A; Cuvellier S; Yacoub-Youssef H; Gherardi RK; Chelly J; Chretien F; Mounier R; Ferry A; Chazaud B
    Muscle Nerve; 2012 Jun; 45(6):803-14. PubMed ID: 22581532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular therapy of muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation.
    Ryu D; Zhang H; Ropelle ER; Sorrentino V; Mázala DA; Mouchiroud L; Marshall PL; Campbell MD; Ali AS; Knowels GM; Bellemin S; Iyer SR; Wang X; Gariani K; Sauve AA; Cantó C; Conley KE; Walter L; Lovering RM; Chin ER; Jasmin BJ; Marcinek DJ; Menzies KJ; Auwerx J
    Sci Transl Med; 2016 Oct; 8(361):361ra139. PubMed ID: 27798264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies.
    Terrill JR; Radley-Crabb HG; Iwasaki T; Lemckert FA; Arthur PG; Grounds MD
    FEBS J; 2013 Sep; 280(17):4149-64. PubMed ID: 23332128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
    Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
    Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.
    Nguyen HH; Jayasinha V; Xia B; Hoyte K; Martin PT
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5616-21. PubMed ID: 11960016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngeal muscles are spared in the dystrophin deficient mdx mouse.
    Thomas LB; Joseph GL; Adkins TD; Andrade FH; Stemple JC
    J Speech Lang Hear Res; 2008 Jun; 51(3):586-95. PubMed ID: 18506037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications.
    Serrano AL; Muñoz-Cánoves P
    Semin Cell Dev Biol; 2017 Apr; 64():181-190. PubMed ID: 27670721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.
    Manning J; Kulbida R; Rai P; Jensen L; Bouma J; Singh SP; O'Malley D; Yilmazer-Hanke D
    Exp Physiol; 2014 Oct; 99(10):1370-86. PubMed ID: 24972834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases.
    Consalvi S; Saccone V; Giordani L; Minetti G; Mozzetta C; Puri PL
    Mol Med; 2011; 17(5-6):457-65. PubMed ID: 21308150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.